CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-03 | Bassler Bonnie L Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −826 | 1,654 | ||
| 2024-01-03 | Fenimore Christopher R. SVP Controller | Option exercise | +5,000 | $555.67 | $2.8M | 19,372 |
| 2024-01-03 | Fenimore Christopher R. SVP Controller | Shares withheld for taxes | −4,043 | $912.30 | $3.7M | 15,329 |
| 2024-01-03 | Fenimore Christopher R. SVP Controller | Option exercise | +5,000 | $399.66 | $2.0M | 20,329 |
| 2024-01-03 | Fenimore Christopher R. SVP Controller | Shares withheld for taxes | −3,469 | $912.30 | $3.2M | 16,860 |
| 2024-01-03 | Fenimore Christopher R. SVP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −5,000 | 5,000 | ||
| 2024-01-03 | Fenimore Christopher R. SVP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −5,000 | 5,000 | ||
| 2024-01-03 | LAROSA JOSEPH J EVP General Counsel and Secret | Option exercise | +34,000 | $399.66 | $13.6M | 64,036 |
| 2024-01-03 | LAROSA JOSEPH J EVP General Counsel and Secret | Shares withheld for taxes | −24,493 | $912.30 | $22.3M | 39,543 |
| 2024-01-03 | LAROSA JOSEPH J EVP General Counsel and Secret | Option exercise · Non-Qualified Stock Option (right to buy) | −34,000 | 0 | ||
| 2024-01-03 | Landry Robert E EVP Finance CFO | Option exercise | +1,100 | $378.98 | $417K | 23,136 |
| 2024-01-03 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −688 | $912.30 | $628K | 22,448 |
| 2024-01-03 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −1,100 | 15,987 | ||
| 2024-01-02 | YANCOPOULOS GEORGE Bd. Co-Chair, President & CSO | Sale 10b5-1 | −16,848 | $900.00 | $15.2M | 180,000 |
| 2024-01-02 | COLES N ANTHONY Director | Grant or award | +135 | 1,393 | ||
| 2024-01-02 | COLES N ANTHONY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,607 | 1,607 | ||
| 2024-01-02 | Zoghbi Huda Y Director | Option exercise 10b5-1 | +1,117 | $391.92 | $438K | 2,364 |
| 2024-01-02 | Zoghbi Huda Y Director | Sale 10b5-1 | −1,117 | $900.00 | $1.0M | 1,247 |
| 2024-01-02 | Zoghbi Huda Y Director | Grant or award 10b5-1 | +135 | 1,382 | ||
| 2024-01-02 | Zoghbi Huda Y Director | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,117 | 0 |
Page 40 of 49 · 971 trades